4.7 Article

Scutellarin acts on the AR-NOX axis to remediate oxidative stress injury in a mouse model of cerebral ischemia/reperfusion injury

期刊

PHYTOMEDICINE
卷 103, 期 -, 页码 -

出版社

ELSEVIER GMBH
DOI: 10.1016/j.phymed.2022.154214

关键词

Scutellarin; Aldose reductase; NADPH oxidase; Ischemia-reperfusion; Quantitative proteomic analysis

资金

  1. National Natural Science Foundation of China [81303115, 81774042, 81771353, 81904104]
  2. Pearl River S & T Nova Program of Guangzhou [201806010025]
  3. Specialty Program of Guangdong Province Hospital of Traditional Chinese Medicine of China [YN2016MJ07, 2015KT1294, YN2015MS02, YN2018ZD07]
  4. Natural Science Foundation of Guangdong Province of China [S2013040016915]
  5. Science and Technology Program of Guangzhou City of China [202102010268]
  6. Postdoctoral Foundation of China [2021M690759, BBK42913K09, 201003345, BBH429151701]
  7. Hong Kong Scholar Program
  8. Guangzhou University [A1-AFD018171Z11096]
  9. Administration of Traditional Chinese Medi-cine of Guangdong Province [20211203]
  10. Youth Pilot Project of Chinese Society of Traditional Chinese Medicine
  11. Research Fund for Zhaoyang Talents of Guangdong Provincial Hospital of Chinese Medicine [ZY2022KY06]
  12. Guangdong Provincial Key Laboratory of Research on Emergency in TCM
  13. [CACM-2018-QNRC2-C09]
  14. [2017B030314176]
  15. [2018-75]
  16. [2019-140]

向作者/读者索取更多资源

This study found that scutellarin has antioxidant effects on cerebral ischemic injury, and this effect is related to the regulation of the Aldose reductase (AR) gene. Scutellarin treatment can improve neurological function deficits and brain damage in an ischemic stroke model, and reduce the expression of oxidation-related products. In addition, the therapeutic effect of scutellarin on reducing cerebral infarction area and neurological function deficits is abolished in AR knockout mice, indicating that scutellarin's effect on cerebral ischemic injury is through regulating the AR gene.
Background: Oxidative stress plays an important role in the pathology of ischemic stroke. Studies have confirmedthat scutellarin has antioxidant effects against ischemic injury, and we also reported that the involvement of Aldose reductase (AR) in oxidative stress and cerebral ischemic injury, in this study we furtherly explicit whether the antioxidant effect of scutellarin on cerebral ischemia injury is related to AR gene regulation and its specific mechanism. Methods: C57BL/6N mice (Wild-type, WT) and AR knockout (AR(-/-)) mice suffered from transient middle cerebral artery occlusion (tMCAO) injury (1 h occlusion followed by 3 days reperfusion), and scutellarin was administered from 2 h before surgery to 3 days after surgery. Subsequently, neurological function was assessed by the modified Longa score method, the histopathological morphology observed with 2,3,5-triphenyltetrazolium chloride (TTC) and hematoxylin-eosin (HE) staining. Enzyme-linked immunosorbent assay (Elisa) was used to detect the levels of ROS, 4-hydroxynonenal (4-HNE), 8-hydroxydeoxyguanosine (8-OHDG), Neurotrophin-3 (NT-3), poly ADP-ribose polymerase-1 (PARP1) and 3-nitrotyrosine (3-NT) in the ischemic penumbra regions. Quantitative proteomics profiling using quantitative nano-HPLC-MS/MS were performed to compare the protein expression difference between AR(-/- )and WT mice with or without tMCAO injury. The expression of AR, nicotinamide adenine dinucleotide phosphate oxidases (NOX1, NOX2 and NOX4) in the ipsilateral side of ischemic brain were detected by qRT-PCR, Western blot and immunofluorescence co-staining with NeuN. Results: Scutellarin treatment alleviated brain damage in tMCAO stroke model such as improved neurological function deficit, brain infarct area and neuronal injury and reduced the expression of oxidation-related products, moreover, also down-regulated tMCAO induced AR mRNA and protein expression. In addition, the therapeutic effect of scutellarin on the reduction of cerebral infarction area and neurological function deficits abolished in AR- /- miceunder ischemia cerebral injury, which indicated that the effect of scutellarin treatment on tMCAO injury is through regulating AR gene. Proteomic analysis of AR(-/-)and WT mice indicated AR knockout would affect oxidation reaction even as NADPH related process and activity in mice under cerebral ischemia conditions. Moreover, NOX isoforms (NOX1, NOX2 and NOX4) mRNA and protein expression were significant decreased in neurons of penumbra region in AR(-/- )mice compared with that in WT mice at 3d after tMCAO injury, which indicated that AR should be the upstream protein regulating NOX after cerebral ischemia. Conclusions: We first reported that AR directly regulates NOX subtypes (not only NOX2 but also NOX1 and NOX4) after cerebral ischaemic injury. Scutellarin specifically targets the AR-NOX axis and has antioxidant effects in mice with cerebral ischaemic injury, providing a theoretical basis and accurate molecular targets for the clinical application of scutellarin.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据